Investors / China / BioTrack Capital
BioTrack Capital
Venture capital · Shanghai, China · Asia Pacific
BioTrack Capital is a venture capital firm established in 2017 that invests in and incubates early-stage biotech, medtech and healthcare cross-disciplinary companies. It manages five funds with total assets under management over USD1.4Bn and has invested in more than 100 portfolio companies.
Invests inHealthcare & BiotechFintech
In its own wordsbiotechmedtechdigital healthconsumer healthcarehealthcare
Your fit with BioTrack Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBioTrack Capital lists 5 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 33% of the companies with a known first round. Its largest themes are Healthcare & Biotech (83%) and Fintech (17%). 80% of its companies are based in United States. It invests most often alongside Qiming Venture Partners, MPC and 3E Bioventures Capital.
Counts come from funding rounds that name BioTrack Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 17% |
| Series A | 33% |
| Series B | 33% |
| Growth | 17% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 1 |
| '26 | 4 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 4th | 5 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 57th | 17% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 83% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Qiming Venture Partners | 3 |
| MPC | 2 |
| 3E Bioventures Capital | 1 |
| 5Y Capital | 1 |
| Abundance Partners | 1 |
| Decheng Capital | 1 |
| Granite Asia | 1 |
| HighLight Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 83% | 15% |
| Fintech | 17% | 12% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Qiming Venture Partners
Compare BioTrack Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with BioTrack Capital| Date | Company | Stage |
|---|---|---|
| 31 Aug 2026 | Seed | |
| 27 Apr 2026 | Series A | |
| 8 Apr 2026 | Series C+ | |
| 10 Dec 2025 | Series B | |
| 4 Sept 2025 | Series A Led |
Round details for BioTrack Capital
Amounts, full round histories and every co-investor in BioTrack Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
5 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Aureka Biotechnologies develops life-saving medicines using artificial intelligence and data-driven design | Healthcare & Biotech | Apr 2026Series A | Funding round | |
| BlossomHill Therapeutics designs and develops innovative small molecules to overcome the limitations of existing cancer therapies. | Healthcare & Biotech | Dec 2025Series B | Funding round | |
| Life Biosciences is a biotechnology company that pioneers cellular rejuvenation using epigenetic restoration to reverse diseases of aging | Healthcare & Biotech | Apr 2026Series C+ | Funding round | |
| Qiming Venture Capital invests in various companies, particularly in the technology and healthcare sectors. | Healthcare & BiotechFintech | Aug 2026Seed | Funding round | |
| Rapafusyn is pioneering RapaGlues, a unique modality of non-degrading molecular glues for targets previously considered intractable | Healthcare & Biotech | Sept 2025Series A | Funding round |
About this data
site last read 5 Nov 2026- Site
- biotrackcapital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 4 Sept 2025
- Companies checked
- 5
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BioTrack Capital's profile as data
Pull BioTrack Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/biotrackcapital.com
# also
GET /v1/firms/biotrackcapital.com/portfolio
GET /v1/firms/biotrackcapital.com/coinvestors
GET /v1/firms/biotrackcapital.com/news